Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Lehne

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
World Journal of Urology|November 1, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims dataJaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
Journal of Comparative Effectiveness Research|May 1, 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in EuropeEllen Brodin, Annie Young, Florian Langer, et al.
The Lancet. Digital Health|January 27, 2023
Secondary data for global health digitalisationAnatol-Fiete Näher, Carina N Vorisek, Sophie A I Klopfenstein, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
World Journal of Urology|November 1, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims dataJaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
Journal of Comparative Effectiveness Research|May 1, 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in EuropeEllen Brodin, Annie Young, Florian Langer, et al.
The Lancet. Digital Health|January 27, 2023
Secondary data for global health digitalisationAnatol-Fiete Näher, Carina N Vorisek, Sophie A I Klopfenstein, et al.
Pageof 3